Medrio

📈 Medrio and ISR Market Research teamed up to survey 88 industry experts in Phase I clinical research. The results? 👉 A deep dive into the challenges and opportunities sponsors face in early phase trials. From balancing data complexity to speeding up database lock—this report offers insights from experts who are shaping the future of Phase I research, including: 🔷First-hand accounts on the evolving terrain of Phase I trials  🔷 Insights on data collection and management 🔷Strategies to speed up transitions from Phase I to Phase II Ready to uncover the why behind the data? Check out the full report here: https://bit.ly/4gC4Yxm

🖥️💫 Missed us at SCOPE? There’s another chance to catch our must-see presentation on AI in clinical trials - this time, from the comfort of your desk! On February 26th, tune in for an encore webinar presentation of ‘AI in Clinical Trials: Simplifying the Path to Insights”, presented by Nicole Latimer and Mike Stocks in collaboration with Fierce Biotech. You’ll walk away with impactful insights on: ➡️ Balancing AI-driven automation with human oversight ➡️Managing data growth without compromising speed, quality, or control ➡️Leveraging machine learning for enhanced trial reporting Register for the webinar here: https://bit.ly/3WXWklM #ClinicalTrials #AI #ArtificialIntelligence #DataManagement

♥️Today, Team Medrio wears red for all our friends, colleagues, and loved ones who have been affected by heart disease.♥️ Heart disease is a leading cause of death in Americans-about 1 in 20 adults aged 20 and older have coronary heart disease [NIH]. Furthermore, nearly half of women ages 20 and older are living with some form of cardiovascular disease [Go Red For Women]. What can we do to change this? Many instances of heart disease are preventable. Raising awareness of the risk factors and how to live a heart-healthy lifestyle can truly make a difference. 👉Check out these resources from the NIH for tips on protecting your heart: https://bit.ly/40Rwilr As researchers, we can do much more to ensure that women are equally represented in cardiovascular clinical trials. In 2020, women represented only 38% of research participants [Go Red For Women].  👉Get involved with Research Goes Red, an initiative aimed at accelerating the understanding of cardiovascular disease and how it uniquely impacts women: https://bit.ly/3CGYqPW #OurHearts #WearRedDay #WearRedandGive

🌴🔵 Is it really the last day already? SCOPE is flying by, but Team Medrio sure is making the most of it! We’re beyond grateful for the chance to have connected with so many brilliant minds across the industry. Thanks for stopping by the booth to catch a magic trick from Medrio solutions expert Geoff Ramler and a sneak preview of Medrio's new AI-Enabled Reporting capabilities! Also, a special shout-out to everyone who joined our presentation on AI in Clinical Trials yesterday afternoon — the turnout was amazing! 🙌 You made the session even more impactful with so many great questions and insights. Didn't have a chance to catch up with the team in Orlando? No worries! We're always available to connect, discuss your biggest research challenges, and how Medrio can help. Book a meeting at your convenience here: https://bit.ly/4hOsXKr #SCOPE #SCOPE25 #AI #ArtificialIntelligence #ClinicalTrials

👋 Hey SCOPE, thanks for bringing the energy to Booth #228! But we're not done yet. Team Medrio is keeping the buzz going with a huge Day 2 focused on AI in clinical trials 👇 Stop by and see the team for: 👀 An exclusive preview of Medrio’s AI-enabled reporting capabilities 🪄Magic tricks and live demos from our Solutions team 📲 The chance to win an iPad and grab some Medrio swag And don't forget to make your way to Panzacola G1 at 4:25PM for a live presentation from Nicole Latimer and Mike Stocks, 'Navigating AI for Clinical Trials: Simplifying the Path to Insights'. Sign up for our final in-booth session on Medrio's AI-Enabled Reporting and add the live presentation to your calendar here: bit.ly/4h0URmi We can't wait to connect with you in Orlando this week! #SCOPE #SCOPE25 #ClinicalTrials #AI #ArtificialIntelligence

💙🚀 20 Years Strong! From the very beginning, Medrio’s mission has been simple: reduce customer pain.  Medrio founder Mike Novotny saw the strain on the industry back in 2005—months of work to build databases and expensive mid-study changes—and knew there had to be a better way. That vision became Medrio. Fast forward two decades, and our commitment to listening to customers and adapting to industry needs is stronger than ever. “Every day, we are talking to [customers] about how their research needs are changing, what it is that is going to most effectively help them to perform efficient and effective, high quality research, and we are making changes to our product and our services to accommodate those needs.”, says Medrio CEO Nicole Latimer. 🎉Join us in celebrating Medrio’s 20th anniversary.  Cheers to many more years of making clinical research more efficient and effective!

SCOPE is coming up next week! As you get prepared and finalize your plans, don’t forget to make sure Medrio is on your schedule.  👉 Wondering how to practically apply AI in your clinical trials? Join Medrio CEO, Nicole Latimer, and CTO, Mike Stocks, for a live presentation on Tuesday (2/4) at 4:25 p.m. ET in Panzacola G1.   👉 Interested in how Medrio is changing the game with AI? Attend one of our in-booth sessions at booth #228. See what AI-enabled reporting capabilities will be available in 2025 and how they can accelerate insight discovery. Learn more about the in-booth sessions and save your seat here: https://bit.ly/4h0URmi

📣 Managing clinical trial data shouldn’t be a bottleneck. That’s why we’re excited to announce the upcoming release of Medrio’s AI-enabled reporting capabilities. ➡️ Simplify data exploration and speed decision-making. Our AI-enabled reporting is built directly into Medrio CDMS/EDC to deliver faster, actionable insights. Get all the details in our latest press release: https://bit.ly/3PUMrBn #AI #ArtificialIntelligence #EDC #CDMS #DataManagement #ClinicalTrials

🔔📅 EU CTR takes effect next week! By January 31, 2025, all ongoing clinical trials in the EU/EEA must comply with the new regulation and be recorded in the Clinical Trials Information System (CTIS). The CTIS will enhance transparency and consistency across trials, but it also introduces new demands for sponsors.  They’ll have to respond to tighter regulatory timelines and increased public access to information. Ensure your team is fully prepared and compliant with the new directive. Check out our blog for a comprehensive readiness checklist and FAQs to get ready for EU CTR: https://bit.ly/3X2AePd #EUCTR #CTIS #CDISC #ClinicalTrials

Experienced CROs choose Medrio for: 🔵Complex study builds in 10-12 weeks vs. 16 weeks 🔵Seamless data entry and management for sites 🔵CTMS integration to accurately track SAEs 🔵Real-time data cleaning and high query resolution rates 🔵Single sign-on from CDMS/EDC to RTSM See how Clinical Trials Resource Group, LLC (CTRG) ensures high-quality data and operational excellence with Medrio: https://bit.ly/3Ck0CN5 #ClinicalTrials #CasteStudy #CDMS #EDC #RTSM